Flowchart Overview
 
6
3
3
6
1
3
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
LYELL-LYL-797-101 Phase I OPEN TO ACCRUAL
3
7
2
1
17
ADICET-ADI-001-BCELL Phase I OPEN TO ACCRUAL
ADP-0000-001-SCR Phase N/A OPEN TO ACCRUAL
ADP-0044-002-SPEARHEAD-1 Phase II OPEN TO ACCRUAL
ADP-0055-001-MAGE-A4-SURPASS Phase I OPEN TO ACCRUAL
ALLOVIR-AVM-003-HC Phase III OPEN TO ACCRUAL *
ARCELLX-ACLX-001-DDBCMA Phase I OPEN TO ACCRUAL
CARSGEN-CT041-ST-02 Phase I OPEN TO ACCRUAL *
CARSGEN-CT053-MM-02 Phase I/II OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase N/A OPEN TO ACCRUAL
FATE-FT576-101-MM Phase I OPEN TO ACCRUAL
GSK-3377794-LTFU Phase N/A OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
INCYTE-INCB-39110-211-CRS Phase II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase N/A OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
LYELL-LYL-797-101 Phase I OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
2
HOFFMANN-BO41932-TAPISTRY Phase II OPEN TO ACCRUAL
MERCK-MK1084-001 Phase I OPEN TO ACCRUAL
2
HOFFMANN-BO41932-TAPISTRY Phase II OPEN TO ACCRUAL
MERCK-MK1084-001 Phase I OPEN TO ACCRUAL
1
CARSGEN-CT041-ST-02 Phase I OPEN TO ACCRUAL *
3
2
3
1
3
1
3
3
3
1
12
12
5
4
2
1
1
2
1
4
4
2
3
8
1
1
6
1
4
2
3
7
3
5
3
1
3
1
3
5
1
3
6
2
1
2
2
1
2
6
3
2
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
9
7
2
1
5
10
5
2
2
3
10
3
1
3
7
6
2
3
4
4
4
2
2
3
6
16
7
1
1
12
4
1
2
1
5
1
1
7
5
4
3
2
1
2
7
13
4
6
12
2
7
3
3
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
12
3
4
8
1
3
2
1
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
4
8
2
3
3
5
10
7
3
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
16
12
3
3
4
3
1
1
5
5
5
4
3
5
5
4
3
4
4
3
3
3
1
1
1
2
2
2
1
1
1
4
3
4
2
1
2
2
1
1
1
1
2
4
5
2
3
2
2
2
6
9
6
8
1
5
6
10
1
12
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
7
ADP-0000-001-SCR Phase N/A OPEN TO ACCRUAL
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL
ALLIANCE-A222004-ANOREXIA Phase III OPEN TO ACCRUAL
ALLOVIR-AVM-003-HC Phase III OPEN TO ACCRUAL *
CTN-1705 Phase III OPEN TO ACCRUAL
IIT-RUNAAS-TILDRAKIZUMAB-AGVHD Phase II OPEN TO ACCRUAL
INCYTE-INCB-39110-211-CRS Phase II OPEN TO ACCRUAL